Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome
- PMID: 10408098
Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome
Abstract
Since menstrual toxic shock syndrome (MTSS) is associated with a predominant clone of Staphylococcus aureus which produces both toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxin A (SEA), we sought to clarify the role of TSST-1 in a tampon-associated vaginal infection model in New Zealand White (NZW) rabbits, using isogenic tst+/sea+ S. aureus mutants in which tst was inactivated by allelic replacement. Rabbits infected with the tst-/sea+ strain became ill within 3 days, with fever, weight loss, conjunctival hyperemia, and lethargy. Mortality was significantly higher with the tst+/sea+ strain compared to its tst-/sea+ isogenic derivative (4/13 vs. 0/14; p < 0.05, Fisher's exact test, 2-tailed). Mean fever index was higher (p < 0.005; t test, 2-tailed) and weight loss more sustained among survivors in the tst+/sea+ group. Furthermore, culture filtrates from the tst+/sea+ strain induced a significantly greater response in mitogenesis and TNF alpha secretion from rabbit splenocytes in vitro compared to the tst-/sea+ isogenic derivative. Thus, regardless of the role of SEA, TSST-1 significantly contributed to both morbidity and mortality in this tampon-associated vaginal infection model in NZW rabbits. This is the first demonstration of the potential role of TSST-1 and SEA in the pathogenesis of MTSS with a MTSS-associated clinical S. aureus strain in a relevant animal model.
Similar articles
-
Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.Microb Pathog. 1999 Aug;27(2):61-70. doi: 10.1006/mpat.1999.0282. Microb Pathog. 1999. PMID: 10458917
-
Animal studies of toxic shock syndrome.Crit Rev Microbiol. 1985;12(1):1-44. doi: 10.3109/10408418509104424. Crit Rev Microbiol. 1985. PMID: 3160540 Review.
-
Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.J Infect Dis. 2003 Sep 1;188(5):743-52. doi: 10.1086/377308. Epub 2003 Aug 14. J Infect Dis. 2003. PMID: 12934191
-
Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.J Infect Dis. 2003 Oct 15;188(8):1142-5. doi: 10.1086/378514. Epub 2003 Sep 30. J Infect Dis. 2003. PMID: 14551884
-
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.Crit Rev Microbiol. 1990;17(4):251-72. doi: 10.3109/10408419009105728. Crit Rev Microbiol. 1990. PMID: 2206394 Review.
Cited by
-
A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells.BMC Genomics. 2007 Jun 14;8:171. doi: 10.1186/1471-2164-8-171. BMC Genomics. 2007. PMID: 17570841 Free PMC article.
-
The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Expert Opin Ther Targets. 2012 Jun;16(6):601-12. doi: 10.1517/14728222.2012.682573. Epub 2012 Apr 25. Expert Opin Ther Targets. 2012. PMID: 22530584 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical